Group One Trading’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-100
Closed -$744 7696
2025
Q4
$744 Sell
100
-1,700
-94% -$12.2K ﹤0.01% 7760
2025
Q3
$12K Sell
1,800
-3,000
-63% -$20.8K ﹤0.01% 7059
2025
Q2
$31.8K Buy
4,800
+3,600
+300% +$25.5K ﹤0.01% 5934
2025
Q1
$11K Buy
1,200
+400
+50% +$4K ﹤0.01% 6196
2024
Q4
$8.4K Buy
800
+100
+14% +$1.18K ﹤0.01% 6188
2024
Q3
$8.37K Buy
+700
New +$6.05K ﹤0.01% 5680
2024
Q2
Sell
-3,200
Closed -$16.6K 6755
2024
Q1
$16.6K Buy
+3,200
New +$15.6K ﹤0.01% 5557
2023
Q3
Sell
-33,900
Closed -$98K 7671
2023
Q2
$98K Buy
+33,900
New +$65.1K ﹤0.01% 4644

Other funds holding BVS

Group One Trading's BVS Position: Q1 2024 in Review

Group One Trading sold out of Bioventus (BVS) in Q1 2024, closing a stake of 10,385 shares — an estimated $50.8K sold.

Group One Trading first reported a position in BVS in Q4 2021 and held it in 4 quarters. The position peaked at $177K in Q4 2021. 84 funds tracked by Wall St. Rank hold BVS as of Q1 2024.

  • Group One Trading reported no remaining Bioventus position as of Q1 2024 after selling out during the quarter.
  • Group One Trading sold 10,385 Bioventus shares in Q1 2024, an estimated $50.8K.
  • Group One Trading first reported a position in Bioventus in Q4 2021 and held it in 4 quarters.
  • Group One Trading's Bioventus position peaked at $177K in Q4 2021.
  • 84 funds tracked by Wall St. Rank held Bioventus as of Q1 2024.

Based on Group One Trading's 13F filing for Q1 2024, filed 10 May 2024.